News and Trends 12 Jul 2022 Legochem Bioscience signs agreement with Glycotope to develop cancer drug …GmbH will develop an antibody drug conjugate (ADC) by combining LBC’s technology with one of Glycotope’s investigational tumor targeting antibodies. ADCs are a class of biopharmaceutical drugs designed as a… July 12, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 23 Oct 2019 Channeling the Power of AI into Personalizing Medicine …established biotech Cambridge Antibody Technology. “I wanted to make a difference to patients’ lives — this was something that really interested me about human biology. That’s why I did biochemistry… October 23, 2019 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2017 German Biotech Reels in €34M for its Cancer-Killing Technology Heidelberg Pharma is developing Antibody Targeted Amanitin Conjugates (ATACs), which combine antibody-drug conjugate technology with the toxin, Amanitin. Heidelberg Pharma has attracted over €34M of investment to support the development… November 21, 2017 - 1 minutemin - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 15 Feb 2022 Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials …its Covid-19 vaccine candidate in June 2021, the German mRNA specialist CureVac pivoted to another candidate. The second-generation mRNA vaccine is being developed in partnership with GSK and showed promise… February 15, 2022 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Apr 2024 Chicago biotech: Seven players advancing the industry …financing round, to advance its oncology therapeutic candidate and develop its nanotechnology platform further. This funding will support the progression of their first oncology candidate, the selection of a second… April 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2017 Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer Regeneron and Sanofi have announced positive early results from a Phase II study investigating their skin cancer antibody, cemiplimab. Despite deciding to end their antibody partnership at the end of… December 13, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2018 Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease …with high triglycerides and higher cardiovascular risk. Staten’s lead candidate, licensed from Belgian biotech argenx, is a human antibody that targets ApoC3, reducing fatty molecules in the blood. Though the… December 17, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jul 2024 From data to discovery: Five bioinformatics companies you should know in 2024 …neuron disease that affects the nerve cells in the spinal cord and brain. The drug candidate VRG50635 is a small molecule PIKfyve inhibitor that was entirely discovered and developed using… July 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Startup Scout 21 Nov 2022 Osivax is designing future-proof influenza and Covid vaccines …T cells must often be tested in tissue samples. “If you can get an antibody-based vaccine that protects well and neutralizes the virus, you wouldn’t need to care that much… November 21, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 26 Feb 2018 This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis …struck gold with its fusion peptide, LEVI-04 (p75NTR-Fc). The drug combines the constant region of the IgG antibody with the neurotrophin receptor, p75. The candidate is able to bind each… February 26, 2018 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2025 Kriya Therapeutics has raised over $1.2 billion, but for what? …Manning, and Asia Alpha. At the time, it was advancing three adeno-associated virus (AAV)-based gene therapy candidates. AAV is widely used in gene therapy as it is not pathogenic and… September 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Mar 2024 Are new treatments for multiple sclerosis on the horizon? …for different forms of multiple sclerosis. Vidofludimus calcium: a potential treatment for multiple sclerosis Mechanism of action of vidofludimus calcium Immunic Therapeutics’ vidofludimus calcium is a drug candidate being tested… March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email